Microalgae-derived peptides with antioxidative and anti-inflammatory properties may alleviate hypertension and regulate dyslipidemia by inhibiting angiotensin-converting enzyme (ACE) and endothelial nitric oxide synthase 148,149. This evidence concerns the gene ACE and metabolic syndrome.